Reviewing TerrAscend (TSNDF) & The Competition

TerrAscend (OTCMKTS:TSNDF) is one of 43 publicly-traded companies in the “Agricultural production – crops” industry, but how does it contrast to its competitors? We will compare TerrAscend to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for TerrAscend and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	1	0	1	3.00
TerrAscend Competitors	315	258	604	34	2.29

As a group, “Agricultural production – crops” companies have a potential upside of 54.91%. Given TerrAscend’s competitors higher possible upside, analysts clearly believe TerrAscend has less favorable growth aspects than its competitors.

Profitability

This table compares TerrAscend and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-23.95%	-31.48%	-11.40%
TerrAscend Competitors	-98.15%	-2,439.03%	-14.56%

Insider & Institutional Ownership

5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility & Risk

TerrAscend has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, TerrAscend’s competitors have a beta of -19.60, suggesting that their average stock price is 2,060% less volatile than the S&P 500.

Earnings and Valuation

This table compares TerrAscend and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TerrAscend	$317.33 million	-$95.54 million	-1.60
TerrAscend Competitors	$1.22 billion	-$827,419.35	6.85

TerrAscend’s competitors have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

TerrAscend beats its competitors on 7 of the 13 factors compared.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.